Microalbuminuria strongly predicts cardiovascular morbidity and mortality, clinical nephropathy, and progression of renal disease in high-risk populations.
Is microalbuminuria a valid predictor of cardiovascular risk in high-risk populations?
Microalbuminuria is a strong predictor of cardiovascular and renal outcomes, warranting routine screening in high-risk diabetic and hypertensive patients.
Absolute Event Rate: 0% vs 0%
Microalbuminuria strongly predicts cardiovascular morbidity and mortality, clinical nephropathy, and progression of renal disease in high-risk populations. We recommend screening patients with type 2 diabetes, older patients with type 1 diabetes, and older patients with stage 2 hypertension or higher (ie, > or = 160/100 mm Hg).
Tagle et al. (Sat,) reported a other. Microalbuminuria strongly predicts cardiovascular morbidity and mortality, clinical nephropathy, and progression of renal disease in high-risk populations.